| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $71.1M | — | -3.2% |
| Cost of Revenue | $49.6M | — | +10.0% |
| Gross Profit | $21.5M | — | -24.2% |
| R&D Expense | $14.2M | — | +14.4% |
| SG&A Expense | $27.7M | — | +9.5% |
| Operating Income | -$34.6M | — | -74.9% |
| Pre-tax Income | -$26.0M | — | -121.6% |
| Income Tax | -$704K | — | -500.0% |
| Net Income | -$24.8M | — | -115.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.4M | -53.4% | -65.2% |
| Accounts Receivable | $69.3M | -18.3% | -3.1% |
| Inventory | $770K | — | — |
| Current Assets | $479.0M | -13.0% | +14.9% |
| Total Assets | $1.16B | -4.7% | -4.1% |
| Current Liabilities | $90.1M | +6.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $7.1M | — | +260.2% |
| Capital Expenditures | $5.2M | — | +10.3% |
| Investing Cash Flow | $10.9M | — | -60.6% |
| Financing Cash Flow | -$44.8M | — | -301.3% |
| Free Cash Flow | $1.9M | — | +120.7% |
| +36.7% |
| Total Liabilities | $112.2M | +5.1% | +35.2% |
| Stockholders' Equity | $1.05B | -5.6% | -6.9% |